辉瑞mRNA流感疫苗三期数据显示其效力比标准疫苗高出34.5%
Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3
#mRNA flu#Pfizer mRNA#flu vaccine#greater efficacy#greater effectiveness
生命科学资讯
生物技术与制药领域的最新动态
制定癌症恶病质治疗路径
Developing a path forward in cancer cachexia
#Pfizer scientists#cachexia Pfizer#path forward#advance understanding#potential treatments
2025-2033年生物技术市场治疗创新与预测报告：聚焦龙沙、安进、先正达、百康、百健、罗氏、诺华、诺和诺德、辉瑞及西雅图遗传学公司 - ResearchAndMarkets.com - 商业电讯
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
#Therapeutic Innovations#Forecast Report#Featuring Lonza#Novo Nordisk#Market Therapeutic